These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23926306)

  • 1. Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia.
    Ma J; Ning YN; Xu M; Hou Y; Wang N; Hou XY; Yu YY; Li H; He WD; Shao LL; Zhou H; Min YN; Liu XG; Shi Y; Qin P; Guo CS; Hou M; Peng J
    Blood; 2013 Sep; 122(12):2074-82. PubMed ID: 23926306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide induce response in patients with corticosteroid-resistant or relapsed ITP by upregulating Neuropilin-1 expression.
    Yang ZG; Wen RT; Zhang YM; Wu GC; Chen WJ; Wang YF; Weng ZY; Wen SS; Zhang XJ; Guan MH
    Int Immunopharmacol; 2019 Jul; 72():437-444. PubMed ID: 31030100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD70-silenced dendritic cells induce immune tolerance in immune thrombocytopenia patients.
    Zhang X; Wang Y; Zhang D; Li H; Zhou Z; Yang R
    Br J Haematol; 2020 Nov; 191(3):466-475. PubMed ID: 32419211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Function of Bone Marrow Mesenchymal Stem Cells from Immune Thrombocytopenia Patients in Inducing Regulatory Dendritic Cell Differentiation Through the Notch-1/Jagged-1 Signaling Pathway.
    Xu LL; Fu HX; Zhang JM; Feng FE; Wang QM; Zhu XL; Xue J; Wang CC; Chen Q; Liu X; Wang YZ; Qin YZ; Kong Y; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
    Stem Cells Dev; 2017 Nov; 26(22):1648-1661. PubMed ID: 28946811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury.
    Lu Z; Chang W; Meng S; Xu X; Xie J; Guo F; Yang Y; Qiu H; Liu L
    Stem Cell Res Ther; 2019 Dec; 10(1):372. PubMed ID: 31801626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of immune response with cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-induced anergic T cells in chronic idiopathic thrombocytopenic purpura.
    Zhang XL; Peng J; Sun JZ; Guo CS; Yu Y; Wang ZG; Chu XX; Hou M
    J Thromb Haemost; 2008 Jan; 6(1):158-65. PubMed ID: 17944988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bone marrow-derived mesenchymal stem cell defects in CD8
    Li H; Guan Y; Sun B; Dou X; Liu X; Xue F; Fu R; Zhang L; Yang R
    Br J Haematol; 2020 Dec; 191(5):852-862. PubMed ID: 32677050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mechanistic Effects and Clinical Applications of Various Derived Mesenchymal Stem Cells in Immune Thrombocytopenia.
    He Y; Ji D; Lu W; Chen G
    Acta Haematol; 2022; 145(1):9-17. PubMed ID: 34515042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic dendritic cells as a target for the therapy of immune thrombocytopenia.
    Fu J; Zhang A; Ju X
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):469-75. PubMed ID: 22387587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.
    Zhang JM; Feng FE; Wang QM; Zhu XL; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
    Stem Cells Transl Med; 2016 Dec; 5(12):1631-1643. PubMed ID: 27471307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated megakaryocyte distribution associated with nestin
    Wang M; Feng R; Zhang JM; Xu LL; Feng FE; Wang CC; Wang QM; Zhu XL; He Y; Xue J; Fu HX; Lv M; Kong Y; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
    Blood Adv; 2019 May; 3(9):1416-1428. PubMed ID: 31053569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell therapy induces FLT3L and CD1c
    Yuan X; Qin X; Wang D; Zhang Z; Tang X; Gao X; Chen W; Sun L
    Nat Commun; 2019 Jun; 10(1):2498. PubMed ID: 31175312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The defective bone marrow-derived mesenchymal stem cells in patients with chronic immune thrombocytopenia.
    Zhang D; Li H; Ma L; Zhang X; Xue F; Zhou Z; Chi Y; Liu X; Huang Y; Yang Y; Yang R
    Autoimmunity; 2014 Dec; 47(8):519-29. PubMed ID: 25019270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.
    Catani L; Sollazzo D; Trabanelli S; Curti A; Evangelisti C; Polverelli N; Palandri F; Baccarani M; Vianelli N; Lemoli RM
    Ann Hematol; 2013 Jan; 92(1):67-78. PubMed ID: 22936460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
    Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML
    Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.
    Ma L; Zhou Z; Zhang D; Yang S; Wang J; Xue F; Yang Y; Yang R
    Thromb Haemost; 2012 May; 107(5):937-50. PubMed ID: 22398715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.
    He Y; Xu LL; Feng FE; Wang QM; Zhu XL; Wang CC; Zhang JM; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
    Br J Haematol; 2018 Feb; 180(3):395-411. PubMed ID: 29327472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Dose Dexamethasone Alters the Increase in Interleukin-16 Level in Adult Immune Thrombocytopenia.
    Wang X; Li L; Wang Y; Li X; Feng Q; Hou Y; Ma C; Gao C; Hou M; Peng J
    Front Immunol; 2019; 10():451. PubMed ID: 30936868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
    Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
    Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB2 Receptor Stimulation and Dexamethasone Restore the Anti-Inflammatory and Immune-Regulatory Properties of Mesenchymal Stromal Cells of Children with Immune Thrombocytopenia.
    Rossi F; Tortora C; Palumbo G; Punzo F; Argenziano M; Casale M; Di Paola A; Locatelli F; Perrotta S
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.